Modulight Spotlights: LASER-SHARP RESEARCH – September 2026
Could locally generated bioluminescence activate photoimmunotherapy for disseminated metastatic disease? Researchers at Northeastern University and Cornell University engineered immune cells to produce blue or red light and activate verteporfin in 3D ovarian cancer spheroid models. While bioluminescence remained below the threshold for effective cytotoxicity, conventional light activation with the ML6500 laser system produced a clear light dose-dependent therapeutic response.
Modulight Spotlights: LASER-SHARP RESEARCH – September 2026 Read More »









